Cholestasis Global Clinical Trials Review, H1, 2015

Cholestasis Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2640CTIDB
  • |
  • Pages: 68
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Cholestasis Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Cholestasis Global Clinical Trials Review, H1, 2015" provides data on the Cholestasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cholestasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cholestasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Cholestasis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Clinical Trials by G7 Countries: Proportion of Cholestasis to Gastrointestinal Clinical Trials 13

Clinical Trials by Phase in G7 Countries 14

Clinical Trials in G7 Countries by Trial Status 15

Clinical Trials by E7 Countries: Proportion of Cholestasis to Gastrointestinal Clinical Trials 16

Clinical Trials by Phase in E7 Countries 17

Clinical Trials in E7 Countries by Trial Status 18

Clinical Trials by Phase 19

In Progress Trials by Phase 20

Clinical Trials by Trial Status 21

Clinical Trials by End Point Status 22

Unaccomplished Trials of Cholestasis 23

Subjects Recruited Over a Period of Time 25

Clinical Trials by Sponsor Type 26

Prominent Sponsors 27

Top Companies Participating in Cholestasis Therapeutics Clinical Trials 28

Prominent Drugs 30

Clinical Trial Profiles 31

Clinical Trial Overview of Top Companies 31

Shire Plc 31

Clinical Trial Overview of Shire Plc 31

Abbott Laboratories 32

Clinical Trial Overview of Abbott Laboratories 32

Zhejiang Hisun Pharmaceutical Co., Ltd. 33

Clinical Trial Overview of Zhejiang Hisun Pharmaceutical Co., Ltd. 33

AlbireoPharma 34

Clinical Trial Overview of AlbireoPharma 34

GlaxoSmithKline plc 35

Clinical Trial Overview of GlaxoSmithKline plc 35

Celgene Corporation 36

Clinical Trial Overview of Celgene Corporation 36

Asklepion Pharmaceuticals, LLC 37

Clinical Trial Overview of Asklepion Pharmaceuticals, LLC 37

Clinical Trial Overview of Top Institutes / Government 38

University of Pittsburgh 38

Clinical Trial Overview of University of Pittsburgh 38

Boston Children's Hospital 39

Clinical Trial Overview of Boston Children's Hospital 39

National Center for Research Resources 40

Clinical Trial Overview of National Center for Research Resources 40

University of California, Los Angeles 41

Clinical Trial Overview of University of California, Los Angeles 41

University of Michigan 42

Clinical Trial Overview of University of Michigan 42

Academic Medical Center 43

Clinical Trial Overview of Academic Medical Center 43

Assistance Publique-Hopitaux de Paris 44

Clinical Trial Overview of Assistance Publique-Hopitaux de Paris 44

Baylor College of Medicine 45

Clinical Trial Overview of Baylor College of Medicine 45

Calicut Medical College 46

Clinical Trial Overview of Calicut Medical College 46

Carle Foundation Hospital 47

Clinical Trial Overview of Carle Foundation Hospital 47

Five Key Clinical Profiles 48

Appendix 66

Abbreviations 66

Definitions 66

Research Methodology 67

Secondary Research 67

About GlobalData 68

Contact Us 68

Disclaimer 68

Source 68

List of Figures

Cholestasis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Cholestasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Cholestasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Cholestasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10

Cholestasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Cholestasis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Proportion of Cholestasis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 13

Cholestasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Cholestasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Proportion of Cholestasis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 16

Cholestasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 17

Cholestasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 18

Cholestasis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 19

Cholestasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 20

Cholestasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21

Cholestasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22

Cholestasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25

Cholestasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26

Cholestasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27

Cholestasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28

Cholestasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 67

List of Tables

Cholestasis Therapeutics, Global, Clinical Trials by Region, 2015* 7

Cholestasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Cholestasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Cholestasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Cholestasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Cholestasis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Proportion of Cholestasis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 13

Cholestasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Cholestasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Proportion of Cholestasis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 16

Cholestasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 17

Cholestasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 18

Cholestasis Therapeutics, Global, Clinical Trials by Phase, 2015* 19

Cholestasis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 20

Cholestasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21

Cholestasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22

Cholestasis Therapeutics, Global, Suspended Clinical Trials, 2015* 23

Cholestasis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 24

Cholestasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25

Cholestasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26

Cholestasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27

Cholestasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Cholestasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

Cholestasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2015* 31

Cholestasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 32

Cholestasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zhejiang Hisun Pharmaceutical Co., Ltd., 2015* 33

Cholestasis Therapeutics Clinical Trials Market, Global, Clinical Trials by AlbireoPharma, 2015* 34

Cholestasis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 35

Cholestasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2015* 36

Cholestasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asklepion Pharmaceuticals, LLC, 2015* 37

Cholestasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2015* 38

Cholestasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2015* 39

Cholestasis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2015* 40

Cholestasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2015* 41

Cholestasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2015* 42

Cholestasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 43

Cholestasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique-Hopitaux de Paris, 2015* 44

Cholestasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2015* 45

Cholestasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Calicut Medical College, 2015* 46

Cholestasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Carle Foundation Hospital, 2015* 47

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Cholestasis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Cholestasis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 161425
Site License
USD 5000 INR 322850
Corporate User License
USD 7500 INR 484275

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com